Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 19/20 | 0.42 |
| ▸ | ERBB2 | P04626 | 10/20 | 0.41 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.41 |
| ▸ | RET | P07949 | 1/20 | 0.41 |
| ▸ | MET | P08581 | 1/20 | 0.41 |
| ▸ | EPHB2 | P29323 | 1/20 | 0.41 |
| ▸ | TEC | P42680 | 1/20 | 0.41 |
| ▸ | EPHB4 | P54760 | 1/20 | 0.41 |
| ▸ | EPHA4 | P54764 | 1/20 | 0.41 |
| ▸ | BTK | Q06187 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | TNK1 | Q13470 | 1/20 | 0.41 |
| ▸ | RIPK3 | Q9Y572 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26109679 | 0.90 | EGFR (0.41) | EGFRERBB2RIPK2RETMET | |
| SCHEMBL30590933 | 0.88 | PIK3CD (0.45) | EGFRERBB2RIPK2RETMET | |
| SCHEMBL31352779 | 0.88 | PIK3CD (0.45) | EGFRERBB2RIPK2RETMET | |
| SCHEMBL27148008 | 0.82 | ENPP1 (0.54) | EGFRERBB2RIPK2RETMET | |
| SCHEMBL4087511 | 0.82 | EGFR (0.56) | EGFRERBB2RIPK2RETMET | |
| SCHEMBL3129523 | 0.82 | EGFR (0.56) | EGFRERBB2RIPK2RETMET | |
| SCHEMBL26112804 | 0.80 | EGFR (0.45) | EGFRERBB2 | |
| SCHEMBL28983503 | 0.79 | EGFR (0.61) | EGFRERBB2RIPK2RETMET | |
| SCHEMBL4091279 | 0.78 | EGFR (0.52) | EGFRERBB2 | |
| SCHEMBL22590150 | 0.78 | EGFR (0.54) | EGFRERBB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023196283-A1 | EGFR INHIBITORS | BLUEPRINT MEDICINES CORPORATION (US) | 2023-10-12 | — | — | WO | disclosed |